Results 171 to 180 of about 5,663,674 (349)

Journal Policies on Conflict of Interest: If this Is the Therapy, What’s the Disease? [PDF]

, 2001
Sheldon Krimsky
openalex   +1 more source

Conflict of Interest in Federal Procurement [PDF]

, 1964
Petrowitz, Harold C.
core   +1 more source

Tonic signaling of the B‐cell antigen‐specific receptor is a common functional hallmark in chronic lymphocytic leukemia cell phosphoproteomes at early disease stages

Molecular Oncology, EarlyView.
B‐cell chronic lymphocytic leukemia (B‐CLL) and monoclonal B‐cell lymphocytosis (MBL) show altered proteomes and phosphoproteomes, analyzed using mass spectrometry, protein microarrays, and western blotting. Identifying 2970 proteins and 316 phosphoproteins, including 55 novel phosphopeptides, we reveal BCR and NF‐kβ/STAT3 signaling in disease ...
Paula Díez, Pablo Juanes‐Velasco, Marina L. García‐Vaquero, Conrad Droste, Alicia Landeira‐Viñuela, Miguel Alcoceba, Helena Fidalgo‐Gómez, Sara Misiego‐Herrero, Almudena Navarro‐Bailón, Mónica Baile, José M. Bastida, Jose Manuel Sanchez‐Santos, Rafael Góngora, Julia Almeida, Marcos Gonzalez‐Diaz, Alberto Orfao, Javier De Las Rivas, Manuel Fuentes   +17 more
wiley   +1 more source

Authorship and Conflict of Interest Statement

Journal of Dental Sciences, 2016
doaj   +7 more sources

Research funding, conflicts of interest, and the “meta-methodology” of public relations [PDF]

, 2002
Sheldon Rampton, John Stauber
openalex   +2 more sources

Conflicts of interest between the prescriber, the regulator and the profit maker [PDF]

, 2001
William F. Holmes
openalex   +1 more source

Conflict of Interest [PDF]

Korean Journal of Family Medicine, 2012
openaire   +2 more sources

On the origins of a Conflict of Interest in the Mutual Fund Industry [PDF]

Cet article traite des conflits d'intérêts existant entre les investisseurs et leur conseiller financier. Des contributions antérieures ont apporté des éclairages sur cette question en considérant soit les montants investis soit l'horizon d ...
Sébastien M. Lemeunier
core  

Erratum: Addendum of Conflict of Interest. [PDF]

J Rheum Dis, 2023
Journal Of Rheumatic Diseases Editorial Office.
europepmc   +1 more source

Ubiquitination of transcription factors in cancer: unveiling therapeutic potential

Molecular Oncology, EarlyView.
In cancer, dysregulated ubiquitination of transcription factors contributes to the uncontrolled growth and survival characteristics of tumors. Tumor suppressors are degraded by aberrant ubiquitination, or oncogenic transcription factors gain stability through ubiquitination, thereby promoting tumorigenesis.
Dongha Kim, Hye Jin Nam, Sung Hee Baek
wiley   +1 more source